Newron Pharmaceuticals S.p.A. (FRA:NP5)
14.88
+0.64 (4.49%)
At close: Oct 20, 2025
Newron Pharmaceuticals Market Cap
Newron Pharmaceuticals has a market cap or net worth of €313.73 million as of October 24, 2025. Its market cap has increased by 101.21% in one year.
Market Cap
313.73M
Enterprise Value
323.20M
Revenue
59.88M
Ranking
n/a
PE Ratio
12.39
Stock Price
€14.88
Market Cap Chart
Since December 12, 2006, Newron Pharmaceuticals's market cap has increased from 194.15M to 313.73M, an increase of 61.59%. That is a compound annual growth rate of 2.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2025 | 313.73M | 69.53% |
| Dec 30, 2024 | 185.06M | 94.99% |
| Dec 29, 2023 | 94.91M | 239.07% |
| Dec 30, 2022 | 27.99M | 0.21% |
| Dec 30, 2021 | 27.93M | -20.96% |
| Dec 30, 2020 | 35.34M | -66.13% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 281.83B |
| Siemens Aktiengesellschaft | 185.73B |
| Deutsche Telekom AG | 139.77B |
| Allianz SE | 133.19B |
| Siemens Energy AG | 84.24B |
| Rheinmetall AG | 81.03B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 70.41B |
| Deutsche Bank Aktiengesellschaft | 54.96B |